The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity
Open accessAbstract
Valproic acid (VPA), a widely prescribed drug for seizures and bipolar disorder, has been shown to be an inhibitor of histone deacetylase (HDAC). Our previous study has demonstrated that VPA pretreatment reduces lipopolysaccharide (LPS)-induced dopaminergic (DA) neurotoxicity through the inhibition of microglia over-activation. The aim of this study was to determine the mechanism underlying VPA-induced attenuation of microglia over-activation using rodent primary neuron/glia or enriched glia cultures. Other histone deacetylase inhibitors (HDACIs) were compared with VPA for their effects on microglial activity. We found that VPA induced apoptosis of microglia cells in a time- and concentration-dependent manner. VPA-treated microglial cells showed typical apoptotic hallmarks including phosphatidylserine externalization, chromatin condensation and DNA fragmentation. Further studies revealed that trichostatin A (TSA) and sodium butyrate (SB), two structurally dissimilar HDACIs, also induced microglial apoptosis. The apoptosis of microglia was accompanied by the disruption of mitochondrial membrane potential and the enhancement of acetylation levels of the histone H3 protein. Moreover, pretreatment with SB or TSA caused a robust decrease in LPS-induced pro-inflammatory responses and protected DA neurons from damage in mesencephalic neuron-glia cultures. Taken together, our results shed light on a novel mechanism whereby HDACIs induce neuroprotection and underscore the potential utility of HDACIs in preventing inflammation-related neurodegenerative disorders such as Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, treatment of microglial cells in vitro with various SCFAs, including valproic acid and butyric acid, elevates levels of acetylation of histone H3 (Chen et al., 2007).”
From Microbiome–microglia connections via the gut–brain axis (2019) · cites this paper as Chen et al., 2007
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Self-citationAnticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Ferrante, R. J., Kubilus, J. K., Lee, J.-H., Ryu, H., Beesen, A. A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi‐Carter, R., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 705
Kim, H. J., Rowe, M. K., Ren, M., Hong, J., Chen, P.-S., & Chuang, D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 560
Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martínez‐Losa, M., Walker, T. R., Duffin, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1468 · Cited by 506
Microglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462
Gárdián, G., Browne, S. E., Choi, D., Klivènyi, P., Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B. C., Ratan, R. R., Ferrante, R. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410210200 · Cited by 456
Ren, M., Leng, Y., Jeong, M. R., Leeds, P. R., & Chuang, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02406.x · Cited by 375
Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C. C., Wilson, B. C., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 356
Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 4×
“The release of TNF-α was measured with a rat TNF-α enzyme-linked immunosorbent assay kit (ELISA) from R&D System (Minneapolis, MN), and the production of nitric oxide (NO) was determined by measuring nitrite accumulations in the supernatant with Griess reagent, as described previously (Liu et al., 2000).”
MethodInfluentialSelf-citationCamelo, S. I., Iglesias, A. H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S., Imitola, J., Durán, G., Assaf, B., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.022 · Cited by 281
Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids
Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., & Salminen, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705682 · Cited by 281
Minamiyama, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh131 · Cited by 260
Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?
Blanchard, F., & Chipoy, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03309-4 · Cited by 241
Leng, Y., & Chuang, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0096-06.2006 · Cited by 189
Peng, G.-S., Li, G., Tzeng, N., Chen, P.-S., Chuang, D., Hsu, Y., Yang, S., & Hong, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 169
Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 164
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses
Moreira, J. M. A., Scheipers, P., & Sørensen, P. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-30 · Cited by 143
Magnus, T., Chan, A., Grauer, O. M., Toyka, K. V., & Gold, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5004 · Cited by 141
Kim, T. I., Yoon, J., Cho, H., Lee, W., Kim, J., Song, Y.-H., Kim, S. N., Yoon, J. H., Kim‐Ha, J., & Kim, Y.-J. (2005) · Nature Immunology · doi:10.1038/ni1159 · Cited by 126
Jeong, M. R., Hashimoto, R., Senatorov, V. V., Fujimaki, K., Ren, M., Lee, M. S., & Chuang, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00350-8 · Cited by 126
Kanai, H., Sawa, A., Chen, R.-W., Leeds, P. R., & Chuang, D. M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500269 · Cited by 124
Allen, M. H., Hirschfeld, R. M. A., Wozniak, P. J., Baker, J. D., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.272 · Cited by 124
Regulation of microglial inflammatory response by histone deacetylase inhibitors
Suuronen, T., Huuskonen, J., Pihlaja, R., Kyrylenko, S., & Salminen, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02004.x · Cited by 123
Dou, H., Birusingh, K., Faraci, J., Gorantla, S., Poluektova, L. Y., Maggirwar, S. B., Dewhurst, S., Gelbard, H. A., & Gendelman, H. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09162.2003 · Cited by 120
Reddy, S. M., Hsiao, K.-C., Abernethy, V. E., Fan, H., Longacre, A., Lieberthal, W., Rauch, J., Koh, J. S., & Levine, J. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.702 · Cited by 110
Neuroprotective Effects of Phenylbutyrate Against MPTP Neurotoxicity
Gárdián, G., Yang, L., Cléren, C., Calingasan, N. Y., Klivènyi, P., & Beal, M. F. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:3:235 · Cited by 107
T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.
Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, S.-W., Leonard, B. E., & Steinbusch, H. W. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.08.005 · Cited by 100
Chan, A., Seguin, R. M., Magnus, T., Papadimitriou, C., Toyka, K. V., Antel, J. P., & Gold, R. (2003) · Glia · doi:10.1002/glia.10258 · Cited by 74
Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia
Elsisi, N. S., Darling‐Reed, S., Lee, E.-S., Oriaku, E. T., & Soliman, K. F. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.087 · Cited by 71
Valproic acid induces caspase 3-mediated apoptosis in microglial cells
Dragunow, M., Greenwood, J. M., Cameron, R. E., Narayan, P. J., O’Carroll, S. J., Pearson, A. G., & Gibbons, H. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.065 · Cited by 67
New method to detect histone acetylation levels by flow cytometry
Ronzoni, S., Faretta, M., Ballarini, M., Pelicci, P. G., & Minucci, S. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20151 · Cited by 66
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity
Neuman, M. G., Shear, N. H., Jacobson-Brown, P., Katz, G. G., Neilson, H. K., Malkiewicz, I. M., Cameron, R., & Abbott, F. S. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00217-x · Cited by 63
Park, J., Woo, M.-S., Kim, S. Y., Kim, W.-K., & Kim, H.-S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.003 · Cited by 63
Martirosyan, A., Leonard, S. S., Shi, X., Griffith, B. N., Gannett, P. M., & Strobl, J. S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096891 · Cited by 62
Wiebe, J. P., & Lewis, M. J. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-9 · Cited by 58
Kim, H.-S., Whang, S.-Y., Woo, M.-S., Park, J., Kim, W.-K., & Han, I. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.006 · Cited by 43
Microglial distribution and apoptosis in fetal rat brain
Wang, C.-C., Wu, C., Shieh, J.-Y., & Wen, C.-Y. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00584-9 · Cited by 23
Wen, X., & Wu, G. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7290 · Cited by 23
Nolte (2001) · doi:10.1002/1098-1136(20010101)33:1
Cited by
Sorted by citations
Regulation of inflammation by short chain fatty acids
Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis
Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.011 · Cited by 891
Multiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Metadata
- Authors
- Chen, P. S., Wang, C.-C., Bortner, C. D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., & Hong, J.-S.
- Affiliations
- National Institutes of Health (US)
- Tri-Service General Hospital (TW)
- National Cheng Kung University (TW)
- Corresponding author
- Hong, J.-S.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 149
- Issue
- 1
- Pages
- 203-212
- ISSN
- 0306-4522 (ISSN-L)
- PMC
- PMC2741413
- OpenAlex
- W2039098916
- Cited by
- 262
- References
- 43
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 12 · 2022: 14 · 2021: 14 · 2020: 10 · 2019: 13 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 22 · 2014: 18 · 2013: 17 · 2012: 16
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (Z01ES090082)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- valproic acid, histone deacetylase inhibitors, microglial apoptosis, lipopolysaccharide, dopaminergic neurotoxicity, trichostatin A, sodium butyrate, mitochondrial membrane potential, histone H3 acetylation, neuroinflammation, neuroprotection, Parkinson's disease, microglial activation
- MeSH terms
- Animals, Animals, Newborn, Brain, Cell Cycle, Cells, Cultured, Dopamine, Dose-Response Relationship, Drug, Enzyme Inhibitors, Female, Lipopolysaccharides, Neuroglia, Neurons, Nitrites, Pregnancy, Rats, Inbred F344, Tumor Necrosis Factor-alpha, Valproic Acid, Apoptosis, In Situ Nick-End Labeling, Rats, Histone Acetyltransferases, Membrane Potential, Mitochondrial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review